Phase 4 Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Subjects Aged > =18 Years With Severe Eosinophilic Asthma Requiring Maintenance Oral Corticosteroids

Condition:   Asthma Interventions:   Drug: Prednisone/ Prednisolone;   Biological: Mepolizumab;   Drug: Salbutamol Sponsors:   GlaxoSmithKline;   Tech Observer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials